Article

TWEAK/Fn14 signalling driven super-enhancer reprogramming promotes pro-metastatic…

medRxiv · 2024 · Sim, N.; Carter, J.-M.; Deka, K.; Tan, B. K. T.; Sim, Y.; Tan, S.-M.; Li, Y.

Key facts

Title TWEAK/Fn14 signalling driven super-enhancer reprogramming promotes pro-metastatic metabolic rewiring in Triple-Negative Breast Cancer
First author Sim, N.; Carter, J.-M.; Deka, K.; Tan, B. K. T.; Sim, Y.; Tan, S.-M.; Li, Y.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.05.15.594291
Devices mentioned K010696, K013842
Product codes mentioned JIS, JPK, JJX, MVU, PFT, PPM

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature